Ashland targets $1.905B-$1.975B sales and $405M-$435M adjusted EBITDA in fiscal 2027 as CapEx rises
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: Ashland (ASH) Q4 fiscal 2026 MANAGEMENT VIEW * Chairman & CEO Guillermo Novo said the company “closed fiscal 2026 with continued strong commercial performance across our core segments” and highlighted Life Sciences sales up 4% and Personal Care sales up…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralAnnual guidance with higher capex; the market will weigh whether spending restores Specialty Additives profitability.AI-generated summary
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets